Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PAREXEL announced the CEO Roundtable on Cancer has again named PAREXEL a CEO Cancer Gold Standard employer.
read more
Medicure announced it and Mauritius have exercised their option to acquire additional interests in Apicore Inc. and Apicore LLC from Apicore's founding shareholders.
read more
Genentech has commenced a Phase 1b/2 study for BL-8040 in combination with atezolizumab (TECENTRIQ).
read more
J. David Enloe, Jr., CEO of Ajinomoto Althea was awarded Most Admired CEO in 2017 by the San Diego Business Journal.
read more
Agilent Technologies announced it has acquired Oxfordshire, U.K.-based Cobalt Light Systems, a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry, applied markets and public safety.
read more
Quanticate has completed an investment initiative to upgrade its pharmacovigilance safety database and its in-house technology platform.
read more
Thermo Fisher Scientific announced the results of a collaboration agreement to enable researchers to combine the results of high-resolution Orbitrap LC/MS experiments with highly curated and organism-specific metabolic pathway and genome data for ...
read more
SQI Diagnostics announced the sale of a Sqid-X system under the terms of an agreement with IRX Therapeutics.
read more
ViraCyte has been awarded $3.75M from National Institutes of Health and the FDA to advance its T cell immunotherapies.
read more
Konica Minolta and Ambry Genetics announced the signing of a definitive agreement for a subsidiary of Konica Minolta to acquire Ambry.
read more
Evotec AG has been awarded a grant for a period of two years from IFB Hamburg to identify and develop therapeutic antibodies directed against novel immune-checkpoints on T-cells to improve future cancer treatments.
read more
Spheryx announced the NIH has awarded the company a Phase II SBIR grant to support the modification of their proprietary Total Holographic Characterization technology.
read more
Following cGMP audit of QuVa Pharma's Sugar Land and Temple, Texas facilities, the California Board of Pharmacy has issued Outsource Facility licenses to both QuVa locations.
read more
Lonza announced it has completed the acquisition of Capsugel from KKR for $5.5 billion in cash, including refinancing of existing Capsugel debt of approximately $2 billion.
read more
Trovagene has formally engaged PRA Health Sciences to conduct Trovagene's Phase 1b/2 clinical trial of PCM-075, a polo-like kinase 1 inhibitor, in patients with AML.
read more